Literature DB >> 24512701

Alcohol misuse and illicit drug use are associated with HCV/HIV co-infection.

D Simon1, R T Michita1, J U Béria2, D C Tietzmann3, A T Stein2, V R Lunge1.   

Abstract

We studied hepatitis C virus (HCV) prevalence and risk factors for HCV infection in a sample of Brazilian HIV-positive patients. A cross-sectional study was conducted with 580 HIV-positive patients from a specialized HIV/AIDS diagnosis and treatment centre in southern Brazil. All patients were interviewed for socio-demographic and risk factors and tested for HCV antibodies and HCV-RNA detection. A multivariate analysis was performed to identify risk factors for HCV infection. A total of 138 (24%) patients had past or chronic hepatitis C. The following risk factors were associated with HCV infection for each gender: alcohol misuse and injecting drug use in women (P < 0·001) and low educational level, smoking drug use, and injecting drug use in men (P < 0·01). These results suggest that alcohol misuse, low educational level, smoking drug use, and injecting drug use are probable risk factors for HCV infection in HIV-positive patients. This information contributes to an understanding of the epidemiology of HIV/HCV co-infection in Brazil.

Entities:  

Mesh:

Year:  2014        PMID: 24512701      PMCID: PMC9151251          DOI: 10.1017/S0950268814000041

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  35 in total

1.  Hepatitis C virus genotypes in Southern Brazil.

Authors:  L P Krug; V R Lunge; N Ikuta; A S Fonseca; H Cheinquer; L S Ozaki; S G Barros
Journal:  Braz J Med Biol Res       Date:  1996-12       Impact factor: 2.590

2.  Hepatitis C virus seroprevalence and risk factors among patients with HIV infection.

Authors:  M C Mendes-Corrêa; A A Barone; C Guastini
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2001 Jan-Feb       Impact factor: 1.846

Review 3.  HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies.

Authors:  Eva A Operskalski; Andrea Kovacs
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

4.  Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City.

Authors:  Chanelle J Howe; Crystal M Fuller; Danielle C Ompad; Sandro Galea; Beryl Koblin; David Thomas; David Vlahov
Journal:  Drug Alcohol Depend       Date:  2005-04-18       Impact factor: 4.492

Review 5.  Hepatitis C and HIV co-infection: a review.

Authors:  Irena Maier; George Y Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities.

Authors:  Holly Hagan; Enrique R Pouget; Ian T Williams; Richard L Garfein; Steffanie A Strathdee; Sharon M Hudson; Mary H Latka; Lawrence J Ouellet
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

7.  High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.

Authors:  M Martell; J Gómez; J I Esteban; S Sauleda; J Quer; B Cabot; R Esteban; J Guardia
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Prevalence of alcohol use disorders and associated factors: a population-based study using AUDIT in southern Brazil.

Authors:  Raúl A Mendoza-Sassi; Jorge U Béria
Journal:  Addiction       Date:  2003-06       Impact factor: 6.526

Review 9.  Global estimates of prevalence of HCV infection among injecting drug users.

Authors:  Carmen Aceijas; Tim Rhodes
Journal:  Int J Drug Policy       Date:  2007-08-07

10.  Viral hepatitis in patients infected with human immunodeficiency virus.

Authors:  Maria Helena P Pavan; Francisco Hideo Aoki; Dinaida Teresa Monteiro; Neiva Sellan L Gonçales; Cecília Amélia F Escanhoela; Fernando L Gonçales Júnior
Journal:  Braz J Infect Dis       Date:  2003-08       Impact factor: 1.949

View more
  8 in total

Review 1.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

2.  Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.

Authors:  Ruth S Mwatelah; Raphael M Lwembe; Saida Osman; Bernhards R Ogutu; Rashid Aman; Rose C Kitawi; Laura N Wangai; Florence A Oloo; Gilbert O Kokwaro; Washingtone Ochieng
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 3.  Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.

Authors:  Fatima Mitiko Tengan; Karim Yakub Ibrahim; Bianca Peixoto Dantas; Caroline Manchiero; Mariana Cavalheiro Magri; Wanderley Marques Bernardo
Journal:  BMC Infect Dis       Date:  2016-11-09       Impact factor: 3.090

4.  A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.

Authors:  Zahid Ahmad Butt; Nabin Shrestha; Stanley Wong; Margot Kuo; Dionne Gesink; Mark Gilbert; Jason Wong; Amanda Yu; Maria Alvarez; Hasina Samji; Jane A Buxton; James C Johnston; Victoria J Cook; David Roth; Theodora Consolacion; Michelle Murti; Travis S Hottes; Gina Ogilvie; Robert Balshaw; Mark W Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

5.  Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals.

Authors:  Zahid A Butt; Nabin Shrestha; Dionne Gesink; Michelle Murti; Jane A Buxton; Mark Gilbert; Robert F Balshaw; Stanley Wong; Margot Kuo; Jason Wong; Amanda Yu; Maria Alvarez; Hasina Samji; David Roth; Theodora Consolacion; Mark W Hull; Gina Ogilvie; Mark W Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  Clin Epidemiol       Date:  2018-08-31       Impact factor: 4.790

6.  The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis.

Authors:  Bereket Duko; Mohammed Ayalew; Getinet Ayano
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-11-14

7.  Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.

Authors:  Camila Fernanda da Silveira Alves; Camila Schultz Grott; Vagner Ricardo Lunge; Jorge Umberto Béria; Daniela Cardoso Tietzmann; Airton Tetelbom Stein; Daniel Simon
Journal:  Genet Mol Biol       Date:  2016-07-25       Impact factor: 1.771

8.  Low prevalence of human immunodeficiency virus and hepatitis C virus co-infection in a medium size city in southern Brazil.

Authors:  Carina Sperotto Librelotto; Daniel Simon; Nilo Ikuta; Vagner Ricardo Lunge
Journal:  Braz J Infect Dis       Date:  2014-07-25       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.